Alan Brochstein, The Cannabis Capitalist

Alan Brochstein, CFA, covers the cannabis industry full time from Houston, running 420 Investor, a subscription-based service for those interested in publicly-traded cannabis stocks, and New Cannabis Ventures, a news and information platform that highlights promising companies and influential investors in the cannabis industry. Before focusing on the cannabis industry in 2013, Alan worked as an independent equity research analyst following two decades as a portfolio manager, trader, and analyst.

Most popular articles

Investing in Cannabis Extraction: 5 Companies to Watch

Alan Brochstein, The Cannabis Capitalist – January 3, 2018

The extraction process is fueling the boom in vaping, edibles, and concentrates. Who's profiting from the trend? Read more

Investing in CBD Companies? Watch Out for These Warning Signs

Alan Brochstein, The Cannabis Capitalist – February 26, 2018

Public interest in cannabidiol (CBD), the non-intoxicating cannabinoid, has skyrocketed in the past year. But not all CBD producers are the same. Read more

Investing in Cannabis? Ask These 3 Questions Before You Do

Alan Brochstein, The Cannabis Capitalist – September 5, 2017

Leafly's new columnist, Alan Brochstein, separates the contenders from the pretenders. Meet the Cannabis Capitalist. Read more

Investing in California Cannabis: Five Options

Alan Brochstein, The Cannabis Capitalist – March 12, 2018

California's new adult-use market opens up new opportunities for investors. Read more

3 Canadian Companies Are Making Big US Cannabis Investments

Alan Brochstein, The Cannabis Capitalist – October 23, 2017

Canadian Bioceutical, iAnthus Capital, and Liberty Health Sciences are moving capital south of the border. Read more

Articles contributed to Leafly (by most recent)

Cannabis Stocks Are Soaring, and This Rally Is Based on Reality

Alan Brochstein, The Cannabis Capitalist – September 5, 2018

Past price spikes have been driven by hope, fear, and wild speculation. This one's different. Alan Brochstein explains why. Read more

How to Capitalize on Canada’s Cannabis Consolidation

Alan Brochstein, The Cannabis Capitalist – August 6, 2018

With the adult use market opening in October, expect to see more mergers and acquisitions. Read more

As Big Companies Go Public, Cannabis Stock Markets Get Legit

Alan Brochstein, The Cannabis Capitalist – July 10, 2018

The make-up of the publicly-traded cannabis sector has improved substantially, with some of the best-known operators and brands now embracing the public markets. Read more

Investing: These 16 Cannabis Companies Are Generating Revenue

Alan Brochstein, The Cannabis Capitalist – June 4, 2018

Revenue isn't the only metric to consider when investing. But it's important—and these cannabis companies are producing it. Read more

You Can Invest in a Cannabis Mutual Fund—But Should You?

Alan Brochstein, The Cannabis Capitalist – May 14, 2018

A number of cannabis mutual funds and ETFs have emerged in the last 18 months, but their records are spotty. Read more

Investing in Australia’s Cannabis Industry: 5 Companies to Watch

Alan Brochstein, The Cannabis Capitalist – April 30, 2018

Australia’s emerging cannabis industry offers investors options to participate. Financial analyst Alan Brochstein weighs in. Read more

Friendlier Feds Change the Game for Cannabis Stocks

Alan Brochstein, The Cannabis Capitalist – April 16, 2018

Trump's Friday announcement of a more hands-off federal approach to legal cannabis sent stocks soaring. Here's how to play it. Read more

Massachusetts Cannabis Investing: Where to Start

Alan Brochstein, The Cannabis Capitalist – April 2, 2018

On July 1, Massachusetts is expected to open the first adult-use market on the East Coast. What are your investing options? Read more